Overview

ALPHA Sitagliptin Add on to Metformin (0431-103)

Status:
Completed

Trial end date:
2009-10-30

Target enrollment:

Participant gender:

Summary

Canadian physicians to experience in real life clinical practice the efficacy and tolerability of adding sitagliptin to their patients who have their glycemic levels inadequately controlled while on metformin

Phase:

Phase 4

Details

Lead Sponsor:

Merck Sharp & Dohme Corp.

Treatments:

Metformin
Sitagliptin Phosphate